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Geoffry Mills, M.D., PhD3, Beth Careyva, M.D.2, Melanie Johnson, MPA, Dierdre Axell-House, BA3, Michael Rosenthal, MD1 
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INTRODUCTION 
 
• The Human Genome Project has led to an exponential increase in the potential use of genetic 
information in health care.  
• The clinical utility of most of this testing is undetermined 
• Healthcare professionals do not have substantial education in genetic medicine.  
• Despite these barriers, genomics will continue to integrate into clinical practice.   
 
Table 1: Characteristics of the Respondents (N=315) DISCUSSION 
• Physicians have low confidence for ordering  and discussing genetic 
testing for hereditary cancers  
• Ordering genomic testing was common 
• Physicians who had previously ordered genetic testing were more 
confident on most tasks related to genetic testing 
• A similar pattern is seen for prior consultation with a genetic 
counselors. 
• Inadequate time and resources to counsel patients related to genetic 
risk were strong barriers 
• Most physicians felt  their hospital or network has adequate 
resources to help patients understand genetic risk and that patients 
were capable of understanding risk 
FUTURE DIRECTIONS AND RESEARCH 
• The predominance of respondents who ordered testing/counseling 
being only “Somewhat Confident” suggest the need for educational 
development in primary care 
• Evidence-based decision support, ideally integrated in HIT, is needed 
• The FDA suspended “23 and me” a Direct-to-Consumer (DTC) 
genetic-testing company for unsubstantiated clinical claims 
References 
1. Green ED, Guyer MS. Charting a course for genomic medicine from base pairs to bedside. Nature. 2011;470:204-213. doi:10.1038/nature09764 
2. Bernhardt BA, Zayac C, Gordon ES, Wawak L, Pyeritz RE, Gollust SE. Incorporating direct-to-consumer genomic information into patient care: attitudes 
and experiences of primary care physicians. Per Med. 2012;9(7):683-692. doi:10.2217/pms.12.80. 
3. Goldsmith L, Jackson L, O’Connor A, Skirton H. Direct-to-consumer genomic testing from the perspective of the health professional: a systematic 
review of the literature. J Community Genet. 2013;4(2):169–80. doi:10.1007/s12687-012-0135-8. 
4. Selkirk CG, Weissman SM, Anderson A, Hulick PJ. Physicians’ preparedness for integration of genomic and pharmacogenetic testing into practice 
within a major healthcare system. Genet Test Mol Biomarkers. 2013;17(3):219–25. doi:10.1089/gtmb.2012.0165. 
5. Powell KP, Christianson C a., Cogswell W a., et al. Educational Needs of Primary Care Physicians Regarding Direct-to-Consumer Genetic Testing. J 
Genet Couns. 2012;21(3):469–478. doi:10.1007/s10897-011-9471-9. 
6. Mainous AG, Johnson SP, Chirina S, Baker R. Academic family physicians’ perception of genetic testing and integration into practice: a CERA study. 
Fam Med. 2013;45(4):257–62. 
7. Passamani E. Educational challenges in implementing genomic medicine. Clin Pharmacol Ther. 2013;94(2):192–5. doi:10.1038/clpt.2013.38. 
8. Burke W. Genetic testing in primary care. Annu Rev Genomics Hum Genet. 2004;5:1–14. doi:10.1146/annurev.genom.5.061903.180029. 
9. Powell KP, Cogswell W a, Christianson C a, et al. Primary care physicians’ awareness, experience and opinions of direct-to-consumer genetic testing. J 
Genet Couns. 2012;21(1):113–26. doi:10.1007/s10897-011-9390-9. 
METHODS 
• A convenience sample of primary care physicians at JeffCare, the Lehigh Valley Health Network, 
and the Christiana Care Health System.   Initial postcards were sent  to describing project.  Two  
weeks later, packets with a link to the survey, a printed copy, a stamped/addressed return envelope 
and a $5 gift card were sent.  Surveys were anonymous. A total of 315 responses out of 833 were 
received; response rate was 37.89% 
• A novel survey consisting of 20 questions, 
• Data analysis using Excel for age, gender, practice type, specialty, affiliation and EMR use. 
Bivariate associations were made comparing either personal characteristics or perceived barriers 
to genomic testing implementation, and confidence in performing genetic testing-based tasks. 
Table 2: Physicians’ confidence in tasks related to genomic medicine 
(N=315) 
Personal Characteristics n % 
Gender 
       Male 166 54.1 
       Female 141 45.9 
Age 
       25-34 48 15.6 
       35-44 78 25.3 
       45-54 86 27.9 
       55-64 79 25.6 
       65-74 11 3.6 
       ≥ 75 6 1.9 
Clinical Role 
       Family Medicine Physician 204 65.8 
       Internal medicine Physician 70 22.6 
Other 36 11.6 
       Practice Setting 
       Rural 20 10.0 
       Suburban 108 54.0 
       Urban 66 35.0 
       Multiple 22 11.0 
Practice Type 
       Academic 92 29.2 
       Private 106 33.7 
       Both  12 3.8 
       Neither 105 33.3 
Healthcare Affiliate 
       JeffCare 68 22.3 
       CCHS/DAFP 129 42.3 
       LVHN 108 35.4 
Use EMR 275 89.0 
Confidence Some High Very 
High 
Total 
Take a thorough family history 46.0% 17.8% 3.5% 67.3% 
Build a family medical history pedigree chart 33.7% 17.8% 4.1% 55.6% 
Assess risk of hereditary disease 42.2% 11.7% 2.5% 56.5% 
Order genetic testing for hereditary cancers 23.8% 4.8% 1.3% 29.8% 
Discuss risks, benefits, limits to genetic testing for 
hereditary cancers 
32.4% 7.9% 0.6% 41.0% 
Counsel patients about whether or not to have genetic 
counseling 
39.4% 11.1% 1.3% 51.7% 
Counsel patients about risk reduction strategies based on the 
results of genetic testing 
32.1% 19.4% 7.6% 59.0% 
































(n=  ) 
                 Yes 78.3% 65.0% 75.0% 55.0% 56.7% 70.0% 
                 No 64.6% 53.1% 52.0% 23.6% 37.0% 47.2% 





                 Yes 75.9% 70.7% 60.3% 43.1% 53.4% 72.4% 
                 No 65.2% 52.0% 55.5% 26.6% 37.9% 46.9% 




I have enough time to counsel patients about genetic risk 18.1% 47.9% 66.0% 
Most patients can understand the concept of risk 4.4% 34.9% 39.4% 
In my practice, I have adequate resources to help patients 
understand genetic risk 
28.9% 50.8% 79.7% 
My hospital or network has adequate resources to help 
patients understand genetic risk 
11.1% 21.3% 32.4% 
Table 4: Perceived barriers to genetic testing in primary care (N= 315) 
PURPOSE 
To assess the awareness, experience, and preparedness of regional primary care providers regarding 
genomic tests. 
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Note: Confidence is defined as the percentage of respondents who had “some” high” or “very high” 
confidence in ability to perform tasks for genetic-based disease. 
Note: Confidence is defined as the percentage of respondents who had “some” high” or “very high” 
confidence in ability to perform tasks for genetic-based disease if they had or had not ordered 
genetic testing or consulted a genetics counselor in the past 6 months. 
